NCT02361099View on ClinicalTrials.gov

SENTINEL : Impact of the Use of a Web-application for the Detection of Lung Cancer Relapse

PHASE3CompletedINTERVENTIONAL
Enrollment

133

Participants

Timeline

Start Date

June 3, 2014

Primary Completion Date

December 31, 2017

Study Completion Date

March 31, 2018

Conditions
Lung Cancer
Interventions
OTHER

Monitoring by SENTINEL application

Patients will connect once a week to SENTINEL application to do a self-evaluation of several symptoms. A CT- scan will be scheduled only when there is an alert of the application

Trial Locations (9)

28018

Centre Hospitalier Général, Chartres

44202

Centre Catherine de Sienne, Nantes

44805

Institut de Cancerologie de l'Ouest - site René Gauducheau, Saint-Herblain

49933

Centre Hospitalier Universitaire, Angers

Institut de Cancerologie de l'Ouest - site Paul Papin, Angers

72000

Centre Jean Bernard, Le Mans

72037

Centre Hospitalier, Le Mans

84918

Institut Sainte Catherine, Avignon

85925

Centre Hospitalier Départemenal, La Roche-sur-Yon

All Listed Sponsors
collaborator

Sivan Innovation Ltd.

INDUSTRY

lead

Weprom

OTHER

NCT02361099 - SENTINEL : Impact of the Use of a Web-application for the Detection of Lung Cancer Relapse | Biotech Hunter | Biotech Hunter